We estimated anti-tumor response of the thermochemotherapy (TC) to the gastrointestinal malignancies in 41 patients; hepatic cancer in 16, pancreatic cancer in 12, intra-abdominal lymph node metastasis in 10 and intra-pelvic cancer in 3, and analyzed the optimal frequency and reposing interval of thermochemotherapy from the effective cases.
Mitomycin C (MMC) and/or cis-diamine dichloroplatium (CDDP) was simultaneously given during hyperthermic treatment using a radio-frequency (13.56 MHz) capacitive heating equipment.We estimate the reduction of the tumor volume by CT scan, changes in the serum levels of tumor makers and findings of clinical improvements. We focused on the four cases which revealed more than 50 % of reduction in the tumor volume after TC; two with liver metastasis of colon cancer, one with unresectable pancreatic cancer and with hepatoma.
Complete or partial response to TC was obtained in 5/16 patients (31%) of the hepatic cancer, in 3/12 patients (25%) of pancreatic cancer in 1/10 patients (10%) of intra-abdominal lymph node metastasis and 1/3 patient (33%) of intra-pelvic cancer. Serum levels of tumor makers, which decreased lower than 50% of pre-treatment level were noted in 6/16 patients (38%) of liver cancer, in 5/12 patients (42%) of pancreatic cancer, 2/10 patients (20%) of lymph node metastasis and in 2/3 patients (66%) of intra-pelvic cancer. In contrast, clinical symptoms improved in 10/16 patients (63%) of liver tumor, in 9/12 patients (75%) of pancreas tumor in 7/10 patients (70%) of lymph node metastasis and 2/3 patients (66%) of intra-pelvic cancer. These favorable effects were not affected by the size of the lesions treated.
In three of the four markedly effective cases, the long term interruption of treatment proved to abolish the antitumor effects of TC. In the last 4 th case in which TC was regularly continued, the tumor size and the serum level of tumor maker is maintained to be effective.
TC is an useful therapy for unresectable and recurrent gastrointestinal cancer taking into account not only antitumor effect but improvement in clinical symptom. It should be noticed in mind that these effects might be disappeared after long term interruption of TC.Therefore, we should emphasize TC should be regularly continued as long as possible, and the other appropriate chemotherapeuic agent should be given when hyperthermia is resumed after the long interruption.
View full abstract